A detailed history of Minot Wealth Management LLC transactions in Avalo Therapeutics, Inc. stock. As of the latest transaction made, Minot Wealth Management LLC holds 34,645 shares of AVTX stock, worth $456,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,645
Previous 34,645 -0.0%
Holding current value
$456,621
Previous $25,000 32.0%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 20, 2022

SELL
$19.68 - $28.68 $1.35 Million - $1.97 Million
-68,765 Reduced 66.5%
34,645 $59,000
Q3 2021

Oct 25, 2021

BUY
$26.16 - $40.68 $2.71 Million - $4.21 Million
103,410 New
103,410 $225,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0

About Avalo Therapeutics, Inc.


  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $124M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Minot Wealth Management LLC Portfolio

Follow Minot Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Minot Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Minot Wealth Management LLC with notifications on news.